China will provide the public with faster, more affordable access to medical innovations between 2026 and 2030, the National Healthcare Security Administration said at a press conference Friday. Measures will include adding more new medicines to the national reimbursement drug list, standardizing medical service insurance coverage nationwide to ensure greater equity, and accelerating the clinical adoption of medical innovations.
September 4, 2026China will expand national health insurance coverage for innovative drugs used to treat cancer, chronic and rare diseases, and childhood illnesses, with the goal of easing the financial burden on patients and their families.
September 4, 2026China's maternity insurance system has continued to expand its coverage and strengthen support for childbirth, with measures to cut out-of-pocket spending on childbirth and ensure more benefits reach the public, according to the National Healthcare Security Administration on Friday.
September 4, 2026